Table 4.
Characteristics of infected patients in pre-IPB and post-IPB groups
| Study Period | Subject | Sex | Age | Implant Type | Infected Surgical site(s) | Time to SSI (months) | Organism(s) |
|---|---|---|---|---|---|---|---|
| Pre-IPB | P1 | F | 48 | ITP | Lumbar wound | 1.0 | Pseudomonas aeruginosas |
| Pre-IPB | P2 | M | 42 | ITP | IT catheter, pump | 0.5 | Pseudomonas aeruginosa, Staphylococcus epidermidis |
| Pre-IPB | P3 | F | 30 | ITP | Lumbar wound | 0.5 | No growth at explant |
| Pre-IPB | P3 | F | 30 | ITP | IT catheter, pump | 1.1 | No growth at explant |
| Pre-IPB | P4 | F | 60 | ITP | IT catheter, pump | 1.3 | Enterobacter aerogenes |
| Pre-IPB | P5 | M | 66 | ITP | IT catheter, pump | 0.3 | Escherichia coli |
| Pre-IPB | P6 | F | 25 | ITP | IT catheter, pump | 0.4 | Escherichia coli |
| Pre-IPB | P7 | M | 37 | ITP | IT pump | 2.1 | Staphylococcus epidermidis |
| Pre-IPB | P8 | M | 24 | ITP | IT pump | 1.5 | No growth at explant |
| Pre-IPB | D1A | M | 73 | DBS | Electrode, IPG | 0.9 | MRSA |
| Pre-IPB | D2A | M | 81 | DBS | Electrode | 0.2 | Morganella morganii |
| Pre-IPB | D3B | M | 72 | DBS | IPG | 5.7 | Staphylococcus aureus, Corynebacterium jeikeium |
| Post-IPB | P9 | F | 57 | ITP | IT catheter, pump | 4.9 | Pseudomonas aeruginosa |
| Post-IPB | P10 | F | 31 | ITP | IT pump | 2.9 | No growth at explant |
| Post-IPB | D4B | M | 64 | DBS | IPG | 4.7 | Staphylococcus epidermidis, Propionibacterium granulosum, Klebsiella oxytoca |
MRSA = Methicillin=resistant staphylococcus aureus
SSI = Surgical site infection
Time in red = time greater than 90 days or 3 months